Monitoring Post-Mortem Gene Transcription in Mice and Zebrafish

Genes linked to embryonic development, stress, and cancer are increasingly transcribed into RNA after these animals die.

Written byJoshua A. Krisch
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

NICHDNinety-six hours after 43 zebrafish were frozen to death and 48 hours after 20 mice had their necks snapped, specific cells within their bodies were still hard at work. Gene transcription continued apace, and occasionally increased, according to a study published today (January 25) in Royal Society Open Biology. Genes linked to embryonic development, stress, and cancer were among those increasingly transcribed into RNA, researchers at the University of Washington and their colleagues reported. The results suggest that organismal death is an orderly, predictable process, and could help forensic scientists pinpoint time of death, plus help explain why organs from recently deceased donors seem to be more prone to cancer.

“Death is a time-dependent process,” said coauthor Peter Noble, whose group studies the postmortem transcriptome and microbiome. “We define the window between the time of organismal death and the time when not all cells are dead as ‘the twilight of death,’” he explained. “We found that there was a successional pattern to this time—more or less waves of transcription abundances. The shutdown is not random, it’s step-wise.”

Forensic scientists have long been interested in how bodies decay, especially as a way of determining time of death in criminal investigations. When Noble first began studying the phenomenon five years ago at Alabama State University, others had already tried to determine time of death by measuring microbial populations on the body surfaces of dead animals. Noble wondered ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies